AnalyzeDirect

R. Vitorino¹, S.-P. Hojjat^1,2, C.G. Cantrell³, A. Feinstein^4,5, L. Zhang¹, L. Lee^6,7, P. O’Connor⁷, T.J. Carroll^3,8, R.I. Aviv^1,2. Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline. American Journal of Neuroradiology. 19 May 2016.

Full Text – Open Access

Publication Date
May 2016

How Analyze was Used
“Lesions were manually traced with Analyze 8.0 software (AnalyzeDirect, Overland Park, Kansas) by an experienced clinician (10 years’ experience) by using phase-sensitive inversion recovery for cortical lesion tracing and proton-density/T2 and T1 scans for WM T2 hyperintense lesions and T1 black hole tracing, respectively.”

Keywords
Multiple sclerosis
Cerebral perfusion
Biomarker
Cognitive impairment
Cortical dysfunction

Author Affiliation(s)
¹Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
²Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada
³Department of Biomedical Engineering, Northwestern University, Chicago, Illinois
⁴Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
⁵Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
⁶Department of Neurology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
⁷Department of Medicine, University of Toronto, Toronto, Ontario, Canada
⁸Department of Radiology, Northwestern University, Chicago, Illinois

Tags: Biomarker, Cerebral Perfusion, Multiple Sclerosis